Xeltis expands Clinical Advisory Board’s expertise with significant EU and US appointments
Two leading US and EU cardiology experts, cardiothoracic surgeon Dr. Gregory Fontana and interventional cardiologist Professor Patrick Serruys, have joined Xeltis’ Clinical Advisory Board. Together with seven other world-renowned members, they support the clinical development of Xeltis’ heart valves, enabling cardiovascular restoration.
“It is an honor to have Doctor Fontana and Professor Serruys to support our progress. The Clinical Advisory Board is central to ensure we address and meet the specific needs of the cardiovascular community and their patients with the most advanced solutions in medical technology,” Xeltis CEO Laurent Grandidier stated.
View the full Clinical Advisory Board